The current tuberculosis (TB) vaccine Mycobacterium bovis bacillus Calmette-Guérin (BCG) is the most widely used vaccine worldwide, but it does not prevent the establishment of latent TB or ...

Mammalian hosts coordinate various cell death pathways as part of the immune defense system against pathogens including ...

Bacille Calmette-Guérin (BCG), an attenuated strain of Mycobacterium bovis, is widely administered as a vaccine for tuberculosis. BCG is also used as a biotherapy for superficial bladder carcinoma.

These days, the disease, which is caused by the bacterium Mycobacterium tuberculosis, is treated with specific antibiotics — sometimes for as long as nine months, the Cleveland Clinic says.

A tuberculosis outbreak in Kansas is one ... though other mycobacteria, like Mycobacterium bovis, can also lead to TB in people, according to the CDC. There are two types of TB that can affect ...

The PPE2 protein of Mycobacterium tuberculosis is secreted during infection and facilitates mycobacterial survival inside the host. The potential mechanism of the progression from latent to active ...

The potential of intranasal vaccination is well known against mucosal pathogens, including Mycobacterium tuberculosis, which helps in the designing of new-generation antituberculous vaccines.

A new study, "Identifying Allosteric Hotspots in Mycobacterium tuberculosis cAMP Receptor Protein" published in Biochemistry, provides key insights into how bacterial cAMP receptor proteins (CRPs) ...